Cure8 topic Medications pharmaphorum.com Lilly nets a second FDA okay for Omvoh, in Crohn's disease Medications Mirikizumab Risankizumab Ustekinumab Guselkumab A new FDA approval means another IL-23 option is formally available for people with moderately to severely active Crohn’s disease, including patients whose disease did not respond to other therapies. This could affect... Jan 16, 2025 Read Summary
